Zhejiang Xianju Pharmaceutical News

Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20241028

Oct 27 21:36 ET

Xianju Pharmaceutical: Announcement of Board Resolutions

Oct 25 12:00 ET

Xianju Pharmaceutical: Announcement of Supervisory Committee Resolutions

Oct 25 12:00 ET

Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240904

Sep 3 21:32 ET

Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240828

Aug 27 21:10 ET

Xianju Pharmaceutical: Announcement on renewing the Company\'s 2024 Audit Institution

Aug 26 12:00 ET

Xianju Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement

Aug 26 12:00 ET

Xianju Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024

Aug 26 12:00 ET

Xianju Pharmaceutical: Semi-Annual Report Board Resolution Announcement

Aug 26 12:00 ET

Zhejiang Xianju Pharmaceutical: Investor Relations Management Information for Zhejiang Xianju Pharmaceutical as of July 19th, 2024

Jul 18 20:46 ET

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240530

May 29 21:04 ET

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240522

May 21 20:54 ET

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240515

May 14 21:42 ET

Zhejiang Xianju Pharmaceutical: Announcement on holding an investor reception day event

May 13 12:00 ET

Zhejiang Xianju Pharmaceutical: Announcement on the approval of prednisolone tablets by the US FDA

May 6 12:00 ET

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240428

Apr 28 07:25 ET

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Activity Record Form 20240425

Apr 25 11:00 ET

Xianju Pharmaceutical: 20240425 (2024-019) Announcement on the Forecast of Daily Related Transactions in 2024

Apr 24 12:00 ET

Xianju Pharmaceutical: 2023 Independent Director Debriefing Report (Liu Bin)

Apr 24 12:00 ET

Xianju Pharmaceutical: Notice on holding the 2023 online performance briefing

Apr 24 12:00 ET